Stock listing

ONCO Stock Price, News, Filings & Events — Oncopeptides Ab

Selected listing: ONCO · OMXSTO · SEK · SE

This page tracks Oncopeptides Ab's ONCO:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ONCO:OMXSTO. ONCO:OMXSTO is the stock-level entry point for investors researching Oncopeptides Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Oncopeptides Ab is a public company traded on the Swedish market under the ticker ONCO. The company has a market capitalization of approximately 65.9 million USD. Oncopeptides focuses on developing innovative therapies for cancer treatment.

ONCO:OMXSTOSEKSEUpdated August 29, 2026
Oncopeptides Ab logo
Ticker
ONCO:OMXSTO
Asset type
Stock
Market cap
$81.8M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK

Oncopeptides Ab ONCO:OMXSTO stock context

This page tracks Oncopeptides Ab's ONCO:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ONCO:OMXSTO. ONCO:OMXSTO is the stock-level entry point for investors researching Oncopeptides Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Oncopeptides Ab is a public company traded on the Swedish market under the ticker ONCO. The company has a market capitalization of approximately 65.9 million USD. Oncopeptides focuses on developing innovative therapies for cancer treatment.

Latest news from Oncopeptides Ab

All Oncopeptides Ab news →

Oncopeptides Ab earnings calls

Research Oncopeptides Ab

Alternate listings